bevacizumab
General
Pronunciation:
be-va-siz-uh-mab

Trade Name(s)
- Abevmy
- Alymsys
- Avastin
- Aybintio
- Bambevi
- Mvasi
- Vegzelma
- Zirabev
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Bevacizumab." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51820/all/bevacizumab.
Vallerand AHA, Sanoski CAC, Quiring CC. Bevacizumab. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51820/all/bevacizumab. Accessed November 30, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Bevacizumab. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51820/all/bevacizumab
Vallerand AHA, Sanoski CAC, Quiring CC. Bevacizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 November 30]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51820/all/bevacizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - bevacizumab
ID - 51820
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51820/all/bevacizumab
PB - F.A. Davis Company
ET - 18
DB - Medicine Central
DP - Unbound Medicine
ER -